| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Y Wang, K Harsanyi, S C Mange. Endogenous activation of dopamine D2 receptors regulates dopamine release in the fish retina. Journal of neurophysiology. vol 78. issue 1. 1997-12-02. PMID:9242292. |
these d2 receptors thus function as presynaptic autoreceptors that inhibit dopamine release from dopaminergic cells. |
1997-12-02 |
2023-08-12 |
Not clear |
| C Castagna, G F Ball, J Balthazar. Effects of dopamine agonists on appetitive and consummatory male sexual behavior in Japanese quail. Pharmacology, biochemistry, and behavior. vol 58. issue 2. 1997-12-01. PMID:9300599. |
the observed partial dissociation between the effects of these dopaminergic agonists on appetitive and consummatory sexual behaviors suggests that these two components of male sexual behavior may be controlled by the action of dopamine through different neuronal systems. |
1997-12-01 |
2023-08-12 |
rat |
| V I Makolkin, V I Podzolkov, T D Bol'shakov. [The characteristics of catecholamine metabolism in patients in the initial stage of hypertension]. Terapevticheskii arkhiv. vol 69. issue 9. 1997-12-01. PMID:9411820. |
patients with early stages of essential hypertension seem to have enhanced secretory and metabolic activity of the sympathetic link of the sympathoadrenal system with associated dopamine dysbolism; relative deficiency of dopaminergic system with activation of dopamine conversion to homovanillic acid in its intact conjugation. |
1997-12-01 |
2023-08-12 |
Not clear |
| Y C Chen, W R Galpern, A L Brownell, R T Matthews, M Bogdanov, O Isacson, J R Keltner, M F Beal, B R Rosen, B G Jenkin. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magnetic resonance in medicine. vol 38. issue 3. 1997-11-28. PMID:9339439. |
we measured the regional selectivity of two different dopaminergic ligands: the dopamine release compound d-amphetamine and the dopamine transporter antagonist 2 beta-carbomethoxy-3 beta-(4-fluoropheny) tropane (cft). |
1997-11-28 |
2023-08-12 |
Not clear |
| V Butterweck, A Wall, U Liefländer-Wulf, H Winterhoff, A Nahrsted. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry. vol 30 Suppl 2. 1997-11-26. PMID:9342772. |
the counteracting effects of drugs known to interfere with the central dopaminergic system strongly suggested that dopamine mediated activity is important for the activity of the extract. |
1997-11-26 |
2023-08-12 |
Not clear |
| G Eisenhofer, A Aneman, P Friberg, D Hooper, L Fåndriks, H Lonroth, B Hunyady, E Meze. Substantial production of dopamine in the human gastrointestinal tract. The Journal of clinical endocrinology and metabolism. vol 82. issue 11. 1997-11-25. PMID:9360553. |
the results show that mesenteric organs produce close to half of the dopamine formed in the body, most of which is unlikely to be derived from sympathetic nerves but may reflect production in a novel nonneuronal dopaminergic system. |
1997-11-25 |
2023-08-12 |
human |
| P Hartvig, R Torstenson, J Tedroff, Y Watanabe, K J Fasth, P Bjurling, B Långströ. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography. Journal of neural transmission (Vienna, Austria : 1996). vol 104. issue 4-5. 1997-11-21. PMID:9295169. |
l-[beta-11c]dopa and [11c]raclopride were found suitable to indicate changes in dopamine synthesis rate and release respectively using pet and can be used to mirror drug-induced changes of brain dopaminergic function. |
1997-11-21 |
2023-08-12 |
monkey |
| A Parsian, Z H Zhan. Human dopamine transporter gene polymorphism (VNTR) and alcoholism. American journal of medical genetics. vol 74. issue 5. 1997-11-20. PMID:9342195. |
the dopamine transporter (dat1) is responsible for taking released dopamine back up into presynaptic terminals and terminating dopaminergic activity. |
1997-11-20 |
2023-08-12 |
human |
| V Coronas, F Féron, R Hen, G Sicard, F Jourdan, E Moys. In vitro induction of apoptosis or differentiation by dopamine in an immortalized olfactory neuronal cell line. Journal of neurochemistry. vol 69. issue 5. 1997-11-20. PMID:9349530. |
mediation of both effects by dopaminergic d2 receptors was supported by several observations: active dopamine doses in micromolar ranges, quinpirole agonism and eticlopride antagonism, d2-characteristic rank order of potency among the three agonists tested, and specific binding of a selective d2-like radioligand to 13.s.1.24 cells. |
1997-11-20 |
2023-08-12 |
rat |
| V Coronas, F Féron, R Hen, G Sicard, F Jourdan, E Moys. In vitro induction of apoptosis or differentiation by dopamine in an immortalized olfactory neuronal cell line. Journal of neurochemistry. vol 69. issue 5. 1997-11-20. PMID:9349530. |
the present data altogether indicated that dopamine commits immortalized olfactory neuronal cells in vitro either to apoptosis or to olfactory-like differentiation via d2 dopaminergic receptors. |
1997-11-20 |
2023-08-12 |
rat |
| R DeLucia, C S Planeta, M P Ferreira, M L Aizenstein, C Scavon. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 30. issue 5. 1997-11-18. PMID:9283632. |
fencamfamine (fcf) is a central stimulant that facilitates central dopaminergic transmission through inhibition of dopamine uptake and enhanced release of the transmitter. |
1997-11-18 |
2023-08-12 |
rat |
| M Jaber, S Jones, B Giros, M G Caro. The dopamine transporter: a crucial component regulating dopamine transmission. Movement disorders : official journal of the Movement Disorder Society. vol 12. issue 5. 1997-11-07. PMID:9380041. |
here we summarize the main findings obtained with these transgenic mice carrying this "genetic defect," leading to a better understanding of the relative contribution of the dopamine transporter regarding locomotor activity, regulation of the expression of peptides under the control of dopaminergic activity, and responses to various drugs targeting the dopamine system. |
1997-11-07 |
2023-08-12 |
mouse |
| D G Le Couteur, P W Leighton, S J McCann, S m Pon. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 12. issue 5. 1997-11-07. PMID:9380062. |
the presynaptic dopamine transporter in nigral dopaminergic neurons confers susceptibility to the cytotoxic effects of the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
1997-11-07 |
2023-08-12 |
Not clear |
| F Blanchet, M L Kemel, C Gauchy, M Desban, S Perez, J Glowinsk. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA. Neuroscience. vol 81. issue 1. 1997-11-06. PMID:9300405. |
these effects result from an inhibition by gaba of the evoked release of dopamine, since the reducing effects of bicuculline on n-methyl-d-aspartate responses were not observed under the complete blockade of dopaminergic transmission by the d1 and d2 receptor antagonists. |
1997-11-06 |
2023-08-12 |
rat |
| B Geter-Douglass, J L Katz, K Alling, J B Acri, J M Witki. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. The Journal of pharmacology and experimental therapeutics. vol 283. issue 1. 1997-11-03. PMID:9336302. |
the effects of these drugs with selectivity for d3/d2 receptors over d1 receptors were compared with those produced by the selective d1 agonists [(+/-)-phenyl-2,3,4,5-tetrahydro-(1h)-3-benzazepine-7,8-diol hydrochloride (skf 38393), (+/-)-6-chloro-7,8-dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-be nzazepine hydrobromide (skf 82958)], a nonselective dopaminergic agonist (apomorphine), and an indirect dopamine agonist (cocaine). |
1997-11-03 |
2023-08-12 |
mouse |
| M R Weed, I A Paul, L P Dwoskin, S E Moore, W L Woolverto. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. The Journal of pharmacology and experimental therapeutics. vol 283. issue 1. 1997-11-03. PMID:9336305. |
the reinforcing effects of many psychomotor stimulants have been related to increased dopaminergic neurotransmission and stimulation of central nervous system (cns) dopamine (da) receptors. |
1997-11-03 |
2023-08-12 |
rat |
| N Lindefors, S Barati, W T O'Conno. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain research. vol 759. issue 2. 1997-10-28. PMID:9221938. |
it appears from our results that ketamine pre-treatment reduces the dynamics of dopaminergic transmission in the prefrontal cortex and may possibly alter the balance between dopamine and serotonin transmission. |
1997-10-28 |
2023-08-12 |
rat |
| M G Rosales, D Martinez-Fong, R Morales, A Nuñez, G Flores, J L Góngora-Alfaro, B Flóran, J Aceve. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience. vol 80. issue 3. 1997-10-27. PMID:9276495. |
these data suggest that glutamate, through n-methyl-d-aspartate receptors, stimulates the release of dopamine from dopaminergic dendrites present in the substantia nigra pars reticulata, and that dopamine in turn stimulates the release of glutamate and gaba. |
1997-10-27 |
2023-08-12 |
rat |
| H Li, G Dryhurs. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease. Journal of neurochemistry. vol 69. issue 4. 1997-10-27. PMID:9326282. |
formation of dhbt-1 requires only dopamine, l-cysteine, and an oxidizing environment, conditions that may well exist in the cytoplasm of neuromelanin-pigmented dopaminergic neurons in the parkinsonian substantia nigra. |
1997-10-27 |
2023-08-12 |
rat |
| R H Mach, M A Nader, R L Ehrenkaufer, S W Line, C R Smith, H D Gage, T E Morto. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacology, biochemistry, and behavior. vol 57. issue 3. 1997-10-23. PMID:9218272. |
microdialysis studies have shown that psychostimulants act through a common neurochemical mechanism of elevating synaptic dopamine content in the mesocorticolimbic dopaminergic system. |
1997-10-23 |
2023-08-12 |
monkey |